| Application of Gaussian Process Regression (GPR) in estimating under-five mortality levels and trends in Iran 1990-2013, study protocol P Mehdipour, I Navidi, M Parsaeian, Y Mohammadi, LM MORADI, ... ARCHIVES OF IRANIAN MEDICINE 17 (3), 189-192, 2014 | 59 | 2014 |
| A comprehensive study on national and sub national trend in thyroid cancer prevalence in the iranian population, 1990–2010 F Farzadfar, N Peykari, B Larijani, S Rahimzadeh, E Rezaei-Darzi, ... Iranian Journal of Diabetes and Metabolism 15 (2), 91-100, 2016 | 24 | 2016 |
| A double-blind, randomized comparison study between Zytux™ vs MabThera® in treatment of CLL with FCR regimen: non-inferiority clinical trial G Toogeh, M Faranoush, SM Razavi, H Jalaeikhoo, A Allahyari, ... International Journal of Hematology-Oncology and Stem Cell Research 12 (2), 84, 2018 | 21 | 2018 |
| Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study R Kelishadi, R Heshmat, F Farzadfar, ME Motlag, M Bahreynian, S Safiri, ... Journal of Cardiovascular and Thoracic Research 9 (1), 12, 2017 | 19 | 2017 |
| Comparison of two data mining techniques in labeling diagnosis to Iranian pharmacy claim dataset: artificial neural network (ANN) versus decision tree model E Rezaei-Darzi, F Farzadfar, A Hashemi-Meshkini, I Navidi, M Mahmoudi, ... Archives of Iranian medicine 17 (12), 0-0, 2014 | 19 | 2014 |
| Is amyloid-β an innocent bystander and marker in Alzheimer's disease? Is the liability of multivalent cation homeostasis and its influence on amyloid-β function the real mechanism? A ManafiRad, F Farzadfar, L Habibi, M Azhdarzadeh, H Aghaverdi, ... Journal of Alzheimer's Disease 42 (1), 69-85, 2014 | 19 | 2014 |
| Detecting diseases in medical prescriptions using data mining tools and combining techniques M Teimouri, F Farzadfar, MS Alamdari, A Hashemi-Meshkini, PA Alamdari, ... Iranian Journal of Pharmaceutical Research: IJPR 15 (Suppl), 113, 2016 | 18 | 2016 |
| Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis M Varmaghani, AH Meshkini, F Farzadfar, M Yousefi, S Yaghoubifard, ... Journal of Research in Pharmacy Practice 4 (2), 51, 2015 | 16 | 2015 |
| National and sub-national prevalence, trend, and burden of asthma in Iran from 1990 to 2013; the study protocol M Varmaghani, A Rashidian, A Kebriaeezadeh, M Moradi-Lakeh, M Moin, ... Archives of Iranian medicine 17 (12), 0-0, 2014 | 16 | 2014 |
| Use of information criteria for selecting a correlation structure for longitudinal cluster randomised trials E Rezaei-Darzi, J Kasza, A Forbes, R Bowden Clinical Trials 19 (3), 316-325, 2022 | 9 | 2022 |
| Assessing the effect of highly cited papers on the impact factor of journals in the field of public health E Rezaei, I Navidi, MB Rokni, MR Pourmand Iranian journal of public health 41 (12), 84, 2012 | 7 | 2012 |
| Level and trend of total plasma cholesterol in national and subnational of Iran: a systematic review and age-spatio-temporal analysis from 1990 to 2016 P Mehdipour, E Mohammadi, SG Sepanlou, A Ahmadvand, N Peykari, ... Journal of Diabetes & Metabolic Disorders 21 (2), 1301-1315, 2022 | 6 | 2022 |
| The impact of iterative removal of low-information cluster-period cells from a stepped wedge design E Rezaei-Darzi, KL Grantham, AB Forbes, J Kasza BMC Medical Research Methodology 23 (1), 1-13, 2023 | 4 | 2023 |
| How representative is the Victorian Emergency Minimum Dataset (VEMD) for population-based injury surveillance in Victoria? A retrospective observational study of administrative … E Rezaei-Darzi, J Berecki-Gisolf, DT Fernando BMJ open 12 (12), e063115, 2022 | 3 | 2022 |
| Wealth-related Inequality in Utilization of Antihypertensive Medicines in Iran: an Ecological Study on Population Level Data A Hashemi-Meshkini, A Kebriaeezadeh, H Jamshidi, A Akbari-Sari, ... Archives of Iranian Medicine 19 (2), 0-0, 2016 | 3 | 2016 |
| Evaluation of COVID-19 treatments in Iran in comparison with local therapeutic recommendations: A population-level study on utilization and costs of prescription drugs A Hashemi-Meshkini, R Koochak, S Nikfar, E Rezaei-Darzi, ... Journal of Research in Pharmacy Practice 11 (1), 1, 2022 | 2 | 2022 |
| The levels and trends of raised total cholesterol at national and sub-national scale in Iran from 1990 to 2016: systematic review and pooled analysis P Mehdipour, SG Sepanlou, F Mohebi, A Ahmadvand, N Peykari, ... | 2 | 2019 |
| Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis E Rezaei-Darzi, P Mehdipour, M Di Cesare, F Farzadfar, S Rahimzadeh, ... Plos one 16 (2), e0246253, 2021 | 1 | 2021 |
